James is the Global Strategic Partnerships Lead for the Antiviral & Diagnostics business at Pfizer. In his role, James is responsible for partnering strategy and third-party collaborations supporting PAXLOVID (Pfizer’s oral COVID-19 antiviral therapeutic), Pfizer’s antiviral pipeline, and the company’s respiratory portfolio. Placing emphasis on novel diagnostic, connected care and new channel solutions, Pfizer’s partnerships enable a more seamless patient journey from testing, to treatment, and in managing vaccinations and chronic conditions. Healthcare innovation plays a key role, bringing care clo...read more